VCNX Projected Dividend Yield
Vaccinex Inc ( NASDAQ : VCNX )Vaccinex is a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat diseases and conditions with unmet medical needs. Co.'s main platform technologies include: semaphorin 4D (SEMA4D) antibody platform, which is the application of its knowledge of SEMA4D biology to develop its main product candidate pepinemab for the treatment of various indications, including cancer and neuroinflammatory and neurodegenerative diseases; and ActivMAb antibody discovery platform, which is a proprietary human antibody discovery platform based on a method for expressing libraries of human monoclonal antibodies on the surface of mammalian pox viruses. 20 YEAR PERFORMANCE RESULTS |
VCNX Dividend History Detail VCNX Dividend News VCNX Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |